A 7-year legal battle against U.S. health insurers filed by doctors has ended with the dismissal of all remaining claims by a U.S. District Court in Florida.
The class-action petition involving about 700,000 physicians had claimed the country's biggest health insurers had unfairly cut their reimbursements, reports The Wall Street Journal.
A summary judgment by U.S. District Judge Federico A. Moreno dismissed all remaining claims against UnitedHealth Group Inc., which was the last major holdout in the case, the Journal reported. Almost all of the other major insurers including Aetna Inc., Cigna Corp. and WellPoint Inc., had since settled the claims.
UnitedHealth had argued it never used the particular claims-reimbursement software system that was mostly the focus of the lawsuit.
"After reviewing thousands of documents, there is simply insufficient evidence of the wrongdoing claimed, i.e. agreeing with their competitors to defraud the doctors," the judge ruled. Lawyers representing the physician and medical groups may consider appealing the decision.
Copyright 2006 by United Press International
Related stories:
Bush administration delaying Medicare fee cut
(AP) -- The Bush administration said Monday it is freezing a scheduled 10 percent fee cut for doctors who treat Medicare patients, giving Congress time to act to prevent the cuts when lawmakers return from a July 4 recess.
US advisory panel OK's 2 new combination vaccines
(AP) -- A federal advisory panel on Thursday endorsed two new combination vaccines designed to reduce the number of needle sticks that young children must endure to get the recommended immunizations.
Study shows high rates, rising costs of alcohol/drug disorders in hospitalized patients
Alcohol abuse more common in insured patients, drug abuse in uninsured
Fourteen percent of patients admitted to the hospital have alcohol/drug abuse and addiction (ADAA) disorders, costs for which have risen sharply in recent years, according to a study in the June issue of the
Journal of Substance Abuse Treatment (JSAT).
Changes in local health care markets affect national patient safety project
A national patient safety initiative involving major corporate employers and employer health care coalitions may set common goals, but success relies greatly on regional health care players and local market factors for actual implementation, says a recent study.
Perspective: Policies must keep pace with genetic progress
Enactment of the Genetic Information Nondiscrimination Act (GINA) of 2008 is a boon to individual patients and for genetic research, write Kathy Hudson, M.K. Holohan, and Francis Collins in the June 19 issue of the
New England Journal of Medicine. But the bill is not a panacea, they note: Employers, health insurers, patients, and doctors now must be educated about its provisions, gaps remain in genetic testing oversight, and there still may be opportunities to misuse genetic information.
Kidney disease worsens in a fourth of African-Americans despite therapy for hypertension
The best available treatment for chronic kidney disease from high blood pressure did not keep the disease from substantially worsening in about a fourth of African-Americans studied, according to long-term results of a National Institutes of Health study published April 28, 2008, in the
Archives of Internal Medicine.
Genetic Information Nondiscrimination Act clears Senate
The Senate passed the Genetic Information Nondiscrimination Act (GINA) on April 24, approving by unanimous consent an amended version of H.R. 493, which passed the House April 25, 2007 by a vote of 420-3. The House is expected to take up the measure again quickly before sending it to President Bush to sign the measure into law.
Sicker patients socked with higher copays
Healthcare analysts said U.S. health insurers are rapidly adopting a new pricing system that is boosting copays for expensive prescription drugs.